Home > Healthcare > Pharmaceuticals > Finished Drug Form > Prothrombin Complex Concentrate Market

Prothrombin Complex Concentrate Market Share

Report ID: GMI11940
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Prothrombin Complex Concentrate Market Share

The competition in the market is marked by intense rivalry, driven by the increasing demand for prothrombin complex concentrates. In addition to global leaders, advanced formulations tailored to specific advantages or accurate results are emerging, particularly in regions like North America, where technological advancements are highly emphasized. New innovations in prothrombin complex concentrates are a key competitive factor, with companies partnering with other manufacturers or research organizations to create high-quality prothrombin complex concentrates that provide efficient results. Thus, continuous innovation and advancements are vital for staying competitive in this fast-evolving industry.

Prothrombin Complex Concentrate Market Companies

Prominent players operating in the prothrombin complex concentrate industry include:

CSL
Baxter
Emergent BioSolutions
Grifols Biologicals
Intas Pharmaceuticals
Kedrion Biopharma
LFB Group
Octapharma
Pfizer
Prothya Biosolutions
Takeda Pharmaceuticals

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global prothrombin complex concentrate industry was valued at approximately USD 2.1 billion in 2023 and is estimated to grow at a 9.4% CAGR from 2024 to 2032, driven by the increased incidence of coagulation disorders and growing demand for plasma-related therapies.

The 4-factor PCC segment dominated the market in 2023, accounting for USD 1.2 billion, due to its quicker onset of action and broader applications, such as for direct oral anticoagulant (DOAC) reversal.

North America's prothrombin complex concentrate industry recorded USD 788.3 million in 2023 and is anticipated to reach USD 1.7 billion by 2032, driven by the increasing prevalence of coagulation disorders, particularly among the aging population.

Key players in the industry include CSL, Baxter, Emergent BioSolutions, Grifols Biologicals, Intas Pharmaceuticals, Kedrion Biopharma, LFB Group, Octapharma, Pfizer, and Prothya Biosolutions.